Hydreight Technologies Inc. Reports Nine Months Ended September 30, 2022 – Yahoo Finance

Hydreight Technologies Inc. started trading under the symbol ‘NURS’ on the TSX Venture Exchange at market open on December 1, 2022.
Hydreight’s licenses, medical director offering, and technology allow med-spas as well as healthcare professionals to be able to offer wellness services, testing, medical and medispa treatments all in the comfort of home or at any other location of the customer’s choice.
Adjusted revenue (see Use of Non-GAAP Financial Measures) for the three months ended September 30, 2022 was $2,338,760 compared to $684,268 for the three months ended September 30, 2021.
Adjusted revenue (see Use of Non-GAAP Financial Measures) for the nine months ended September 30, 2022 was $5,612,587 compared to $1,640,001 for the nine months ended September 30, 2021.
Adjusted gross margin for the three months ended September 30, 2022, was $1,023,209 compared to $181,032 for the corresponding prior period.
Adjusted gross Margin for the nine months ended September 30, 2022, was $2,255,180 compared to $525,802 for the comparative period.
In 2021 Hydreight welcomed approximately 101 new business partners, and in 2022, Hydreight has obtained approximately 537 new business partners as of the end of October (an approx. 606% Growth Rate in YOY new business partner sign-ups).
VANCOUVER, British Columbia, Dec. 09, 2022 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (formerly Perihelion Capital Ltd.) (“Hydreight” or the “Company”) (TSXV: NURS) is pleased to announce that it has filed its consolidated condensed interim financial statements for the three and nine months ended September 30, 2022.
Shane Madden, CEO of Hydreight: “We are excited by the Company’s continued growth from quarter to quarter throughout 2022. The Company’s growth from 2021 to 2022 has been exceptional and many contributing factors have led to that expansion, such as industry changing platform offerings, targeted audience strategies as well as expanding the Company’s various divisions to support the tremendous growth. The Company’s aim is to strongly continue this trajectory into 2023 and widen the scope of offerings the platform currently provides.”
Financial Highlights:
Working Capital
Cash & cash equivalents $247,524
Revenue
Revenue for the three months ended September 30, 2022 was $1,136,510 compared to $357,235 for the three months ended September 30, 2021. Revenue for the nine months ended September 30, 2022 was $2,573,297 compared to $841,990 for the nine months ended September 30, 2021.
Cost of Goods Sold
Cost of goods sold for the three months ended September 30, 2022, was $546,490 compared to $184,160 for the corresponding prior year period. For the nine months ended September 30, 2022, cost of goods sold was $1,310,520 compared to $357,060 for the comparative period.
Gross Margin
The gross margin for the three months ended September 30, 2022, was $590,020 or 52% compared to $173,076 or 48% for the corresponding prior period. For the nine months ended September 30, 2022, gross margin was $1,262,778 or 49% compared to $484,930 or 58% for the comparative period.
The Company’s consolidated financial statements for the three and nine months ending September 30, 2022 are available under the Company’s profile on SEDAR (www.sedar.com).
Business Highlights:
About Hydreight
Hydreight’s business was founded in April, 2018, in the State of Nevada, United States to fill an ever evolving void between patients, healthcare professionals and service advisors, and bridge the gap between the corporate practice of medicine, legal compliance and customer convenience. Hydreight’s licenses, medical director offering, and technology allow med-spas as well as healthcare professionals, such as nurses, to be able to offer their services, which includes IV drip, Botox, COVID-19 testing, and other medical and medispa treatments all in the comfort of home or at any other location of the customer’s choice (such as the office, hotels, or other locations outside of hospitals and medical clinics). Hydreight aims to be a one stop shop for service providers to monetize their credentials outside of a fixed setting such as a hospital or medical clinic.
Hydreight currently offers its mobile and telehealth medical services in 42 U.S. states and has established key relationships and supply network chains with major vendors including: Medline, Mckesson, Allergan (Botox), Galderma and numerous pharmacies. Hydreight aims to empower pharmacies to provide their products to service providers in a direct and easily accessible manner.
On February 10, 2021, IV Hydreight Inc. was acquired by Victory Square Technologies Inc. (“VST”) (CSE:VST) (OTC:VSQTF). Pursuant to the Company’s transaction with IV Hydreight Inc., VST sold its interest in IV Hydreight Inc. and now owns approximately 73.72% of the issued and outstanding common shares of the Company (the “Common Shares”).
Hydreight had secured master vendor contracts with strategic 503B compounding pharmacies to facilitate the offering of its platform in all 50 states of the United States. Hydreight is acting as an Uber for nurses that can offer their services on a part time or full time basis directly to patients, allowing consumers to book appointments online, in person or through telehealth platforms with certified and registered health professionals.
In 2021 Hydreight welcomed approximately 101 new business partners, and in 2022, Hydreight has obtained approximately 537 new business partners as of the end of October, and expects to obtain an aggregate of 725 new business partners by the end of the year. (an approx. 606% Growth Rate in YOY new business partner sign-ups)

 
2021
2022
January

4
22
February
5
13
March
9
38
April
10
37
May
9
63
June
2
68
July
13
49
August
4
73
September
6
71
October
14
103
Total
76
537
*Numbers are approximate and provided by Hydreight Management
Company also announces that, subject to the approval of the TSX Venture Exchange (the “Exchange”), it has engaged the services of Independent Trading Group (“ITG”) pursuant to an agreement between the Company and ITG dated December 1, 2022 (the “Agreement”), to provide market-making services in accordance with the policies of the Exchange. ITG is a brokerage firm dedicated specifically to professional trading. Pursuant to the Agreement, ITG will trade the common shares of the Company listed on the Exchange (the “Common Shares”) and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Common Shares. All funds used by ITG in the provision of its market-making services to the Company are funds of ITG.
Under the Agreement, ITG will receive compensation of CAD $5,000 a month, payable monthly in advance. The Agreement is for an initial term of three months and will renew automatically for additional one-month terms until terminated pursuant to the terms of the Agreement. The Agreement may be terminated by either party with 30 days notice. There are no performance factors contained in the Agreement and ITG will not receive shares, options or other equity incentive securities as compensation. ITG is not a Related Party or an Associate (as such terms are defined in the policies of the Exchange) to the Company. Neither ITG nor its principals have an interest, directly or indirectly, in the securities of the Company, other than Mr. Christopher Kaplan, VP Market Maker, Issuer Services of ITG, who owns 635 Common Shares.
Additional information regarding Hydreight can be viewed on its website at www.hydreight.com.
On behalf of the Board of Directors
Shane Madden
Director and Chief Executive Officer
Hydreight Technologies Inc.
www.hydreight.com
Telephone: (480) 790 6886
For further information about Hydreight, please contact:
Investor Relations
Contact – Abbey Vogt
Email: ir@hydreight.com
Telephone: (480) 790 6886
Marketing and Media Contact- Jessica Friedman
Email: jess@hydreight.com
Telephone: (480) 790 6886
Use of Non-GAAP Financial Measures:
This release contains references to non-GAAP financial measures Adjusted Revenue and Adjusted Gross Margin. The Company defines Adjusted Revenue as gross cash income before adjustment for the deferred portion of business partner contract revenue and gross receipts from Hydreight App service sales. The Company defines Adjusted Gross Margin as Adjusted Revenue less business partner payouts on App service sales and pharmacy cost of sales. There is no comparable GAAP financial measure presented in IV Hydreight Inc. and Hydreight Technologies Inc condensed consolidated interim financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measure. The Company believes that the measure provides information useful to its shareholders in understanding the Company’s performance, and may assist in the evaluation of the Company’s business relative to that of its peers. This data is furnished to provide additional information and does not have any standardized meaning prescribed by GAAP. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP, and is not necessarily indicative of other metrics presented in accordance with GAAP.
Neither TSXV nor its Regulation Services Provider (as that term is defined in policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. This press release does not constitute an offer of securities for sale in the United States. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States absent U.S. registration or an applicable exemption from U.S. registration requirements.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: expectations regarding the number of new business partners of Hydreight by the end of 2022.
Investors are cautioned that forward-looking information is not based on historical facts but instead reflect the Company’s management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the ability to obtain requisite regulatory and other approvals with respect to the business operated by the Company and/or the potential impact of the listing of the Company’s shares on the TSXV on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation; and the diversion of management time as a result of being a publicly listed entity. This forward-looking information may be affected by risks and uncertainties in the business of the Company and market conditions.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Related Quotes
Millennials have given up on stocks. Is it time to follow suit?
Cathie Wood makes big bets on potential huge winners. But Ark Invest's top 10 holdings, including Tesla and Roku, have tumbled in 2022.
The billionaire entrepreneur fears that the economic downturn will become worse if this decision is made.
Whilst it may not be a huge deal, we thought it was good to see that the Bankwell Financial Group, Inc. ( NASDAQ:BWFG…
Many experts have a bleak forecast for the stock market early next year. "These types of companies have more resilience in the face of economic uncertainty than companies that don't have significant competitive advantages," Morningstar investment specialist Susan Dziubinski wrote in a commentary. "Given their prices and economic vulnerability, we think these stocks are ones to cut loose going into the new year."
Axsome Therapeutics (NASDAQ: AXSM) has absolutely sizzled this year. The biotech stock has more than doubled, with most of the gain coming in just the last couple of months. It should file for FDA approvals of AXS-07 in treating migraine and AXS-14 in treating fibromyalgia next year as well.
Holding a stock forever may seem crazy, but it's the right way to think about investing in dividend stocks. Companies that generate increasing amounts of cash and return that cash to shareholders can drive a market-beating portfolio, and Travis Hoium highlights four of his buy-and-hold dividend stocks in the video below.
Time flies. But it also crashes.
Consensus for early in the year points to recession-related weakness in earnings and this likely portends choppy equities. Mike Wilson from Morgan Stanley and David Kostin of Goldman Sachs, in fact, predict the S&P 500 will drop to 3600 or lower in the first half of the year, followed by a second-half rebound. Mike Wilson's record on market direction has been remarkably prescient in recent years; his calls shape the current Wall Street consensus as other strategists follow his market outlook.
Investors who bet on a decline in the electric vehicle maker's stock price in the short term have won the jackpot.
Canoo (NASDAQ: GOEV) and Nikola (NASDAQ: NKLA) are both electric vehicle makers that went public by merging with special purpose acquisition companies (SPACs) in 2020. Canoo's stock hit an all-time high of $22 per share in December 2020, but it now trades at about $1. Canoo produces electric delivery vehicles.
The last 747 came off the assembly line this past week. The four-engine plane could carry 500 passengers, with an entire second deck. But that very size sealed its fate.
In this article, we discuss 10 best December dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their returns over the years, and go directly to read 5 Best December Dividend Stocks to Buy. With inflation at its 40-year high, dividend stocks offer one of the best ways to generate […]
Since each of the three major U.S. stock indexes hit their record highs between mid-November 2021 and the first week of January 2022, the Dow Jones Industrial Average has fallen 22% and the S&P 500 is down 28%. The tech-dependent Nasdaq Composite has taken the brunt of the pain, down 38%. Although we'll never know when a bear market will begin, how long it'll last, or how steep the decline will be, we do know that every bear market, crash, and correction throughout history (save for the current bear market) was eventually erased by a bull market.
First, develop a plan (some might call it a budget), said Robert Gilliland, managing director and senior wealth adviser at Concenture Wealth Management. Take into consideration every single possible expense you anticipate after your husband dies, and account for inflation as well. You can break these expenses down into the short term, such as one to five years, the intermediate term, which would be the six- to 10-year span, and the long term, or beyond 10 years.
Warren Buffett probably doesn't think much about passive income when he invests. Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) portfolio includes a handful of dividend stocks that deliver monster yields at today's share prices. Berkshire Hathaway initiated a position in Paramount Global (NASDAQ: PARA) earlier this year.
The Nasdaq Composite index has dropped by around 30% since January, and a few growth names fell by more than 90% from their peak. Justin Pope (Microsoft): From its founding in 1975, Microsoft has grown into one of the world's largest companies, a technology conglomerate with a $1.8 trillion market cap today. Technology companies can have difficulty staying relevant in an industry where there's always new competition emerging.
JPMorgan Chase says ongoing inflation and an outlook for sharply lower returns for investors means that retirees should toss the long-standing 4% rule. That's the rule that says retirees can safely draw down their savings by 4% per year without … Continue reading → The post JPMorgan Says You Can Safely Withdraw This Much From Your Retirement Accounts Yearly appeared first on SmartAsset Blog.
The technology sector is home to many of the best stocks to buy or watch, although it's slim pickings these days.
While the Dow has recovered some from its recent lows, there are several Dow stocks that are no-brainer buys right now.

source